These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9714245

  • 21. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
    Kadish AS, Timmins P, Wang Y, Ho GY, Burk RD, Ketz J, He W, Romney SL, Johnson A, Angeletti R, Abadi M, Albert Einstein Cervix Dysplasia Clinical Consortium.
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
    [Abstract] [Full Text] [Related]

  • 22. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
    Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E.
    J Natl Cancer Inst; 1997 Feb 05; 89(3):245-50. PubMed ID: 9017005
    [Abstract] [Full Text] [Related]

  • 23. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 05; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 24. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction.
    Lehtinen M, Luukkaala T, Wallin KL, Paavonen J, Thoresen S, Dillner J, Hakama M.
    J Clin Virol; 2001 Aug 25; 22(1):117-24. PubMed ID: 11418359
    [Abstract] [Full Text] [Related]

  • 26. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.
    Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N.
    Int J Cancer; 2013 Nov 25; 133(9):2172-81. PubMed ID: 23588935
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov 25; 7(11):1035-41. PubMed ID: 9829713
    [Abstract] [Full Text] [Related]

  • 29. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL.
    J Natl Cancer Inst; 2003 Sep 03; 95(17):1336-43. PubMed ID: 12953088
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
    Adam E, Berkova Z, Daxnerova Z, Icenogle J, Reeves WC, Kaufman RH.
    Am J Obstet Gynecol; 2000 Feb 03; 182(2):257-64. PubMed ID: 10694321
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov 03; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions.
    Chuerduangphui J, Pientong C, Swangphon P, Luanratanakorn S, Sangkomkamhang U, Tungsiriwattana T, Kleebkaow P, Burassakarn A, Ekalaksananan T.
    Med Oncol; 2018 May 09; 35(6):93. PubMed ID: 29744680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.